BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22872462)

  • 1. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.
    Stecco A; Lombardi M; Leva L; Brambilla M; Negru E; Delli Passeri S; Carriero A
    Radiol Med; 2013 Apr; 118(3):465-75. PubMed ID: 22872462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus
    Sun W; Li M; Gu Y; Sun Z; Qiu Z; Zhou Y
    AJR Am J Roentgenol; 2020 Feb; 214(2):446-454. PubMed ID: 31799866
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
    Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
    Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
    Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
    Hong GS; Chae EJ; Ryu JS; Chae SY; Lee HS; Yoon DH; Suh C
    Cancer Imaging; 2021 Jan; 21(1):5. PubMed ID: 33413685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT.
    Manenti G; Cicciò C; Squillaci E; Strigari L; Calabria F; Danieli R; Schillaci O; Simonetti G
    Eur J Radiol; 2012 Aug; 81(8):1917-25. PubMed ID: 21908120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
    Maggialetti N; Ferrari C; Minoia C; Asabella AN; Ficco M; Loseto G; De Tullio G; de Fazio V; Calabrese A; Guarini A; Rubini G; Brunese L
    Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
    Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer.
    Papageorgiou I; Dvorak J; Cosma I; Pfeil A; Teichgraeber U; Malich A
    Clin Transl Oncol; 2020 Aug; 22(8):1321-1328. PubMed ID: 31858434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.
    Cascini G; Falcone C; Greco C; Bertucci B; Cipullo S; Tamburrini O
    Radiol Med; 2008 Dec; 113(8):1157-70. PubMed ID: 18958408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?
    Petralia G; Padhani A; Summers P; Alessi S; Raimondi S; Testori A; Bellomi M
    Eur Radiol; 2013 Dec; 23(12):3466-76. PubMed ID: 23884300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body MRI: detecting bone metastases from prostate cancer.
    Nakanishi K; Tanaka J; Nakaya Y; Maeda N; Sakamoto A; Nakayama A; Satomura H; Sakai M; Konishi K; Yamamoto Y; Nagahara A; Nishimura K; Takenaka S; Tomiyama N
    Jpn J Radiol; 2022 Mar; 40(3):229-244. PubMed ID: 34693502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer: A Diagnostic Test Accuracy Study.
    Rockall AG; Li X; Johnson N; Lavdas I; Santhakumaran S; Prevost AT; Punwani S; Goh V; Barwick TD; Bharwani N; Sandhu A; Sidhu H; Plumb A; Burn J; Fagan A; Wengert GJ; Koh DM; Reczko K; Dou Q; Warwick J; Liu X; Messiou C; Tunariu N; Boavida P; Soneji N; Johnston EW; Kelly-Morland C; De Paepe KN; Sokhi H; Wallitt K; Lakhani A; Russell J; Salib M; Vinnicombe S; Haq A; Aboagye EO; Taylor S; Glocker B
    Invest Radiol; 2023 Dec; 58(12):823-831. PubMed ID: 37358356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.